The Health Minster of Panama, Luis Sucre, said on 7 February 2021 that Panama is seeking to acquire over eight million COVID-19 vaccine doses to inoculate about 80% of the country's residents, Reuters news agency reported on Monday.
According to Sucre, Panama has requested about one million doses from the COVID-19 vaccine portfolio under the COVAX facility coordinated by the World Health Organisation to support lower-income countries.
It will acquire a further three million doses from US pharmaceutical firm Pfizer Inc and the same amount from Russia, which has developed the Sputnik V COVID-19 vaccine.
Sucre added that Panama also aims to acquire 1.1 million doses manufactured by AstraZeneca PLC and 300,000 shots produced by Johnson & Johnson.
Reportedly, Panama has a population of about 4.2 million people but most COVID-19 vaccines require two shots spaced several weeks apart.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline